cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.24993849
title: Supplementary Material for: Effects of extracorporeal blood flow rates on patient tolerance for LIXELLE® treatment during outpatient hemodialysis

description: Introduction: Accumulation of β2-microglobulin (B2M) in dialysis patients contributes to several comorbidities of end stage kidney disease (ESKD). The LIXELLE® device adsorbs B2M from blood using sorbent bead technology. Studies in Japan showed LIXELLE treatment during hemodialysis (HD) at blood flow rates up to 250 mL/min removes B2M above HD alone and is well-tolerated. We investigated tolerance for LIXELLE treatment during HD at higher HD blood flow rates standard in the United States (US).
Methods: A prospective, open-label, non-randomized, single arm, early feasibility study (EFS) assessed tolerance and safety of LIXELLE treatment during HD at blood flow rates up to 450 mL/min. ESKD patients (40-75 years old) on thrice weekly outpatient HD were eligible. After a one-week HD run-in, patients received LIXELLE plus HD at a blood flow rate of 250 mL/min (one week), followed by LIXELLE plus HD at a blood flow rate up to 450 mL/min (one week). These blood flow rates were tested with three LIXELLE column sizes in sequence (treatment = six weeks). B2M removal was assessed for each combination. 
Results: Ten patients with a historic intradialytic hypotension (IDH) rate of 0.42 events/HD session/patient were enrolled. Nine patients completed all combinations without IDH events (treatment IDH rate 0.56 events/HD session/patient). No treatment-emergent serious adverse events or significant changes in red blood cell, platelet, or complement indices except haptoglobin were reported. B2M reduction ratios and removal of select proteins (&lt;40 kDa) increased with escalating column size and blood flow rate. 
Conclusion: LIXELLE plus HD across all column sizes was safe and well-tolerated at blood flow rates up to 450 mL/min. Extent of B2M removal corresponded to column size-blood flow rate combinations. This EFS provides a risk profile to guide further studies of LIXELLE in ESKD patients at US-standard blood flow rates.
DOI: 10.6084/m9.figshare.24993849.v1
title: Supplementary Material for: Effects of extracorporeal blood flow rates on patient tolerance for LIXELLE® treatment during outpatient hemodialysis

description: Introduction: Accumulation of β2-microglobulin (B2M) in dialysis patients contributes to several comorbidities of end stage kidney disease (ESKD). The LIXELLE® device adsorbs B2M from blood using sorbent bead technology. Studies in Japan showed LIXELLE treatment during hemodialysis (HD) at blood flow rates up to 250 mL/min removes B2M above HD alone and is well-tolerated. We investigated tolerance for LIXELLE treatment during HD at higher HD blood flow rates standard in the United States (US).
Methods: A prospective, open-label, non-randomized, single arm, early feasibility study (EFS) assessed tolerance and safety of LIXELLE treatment during HD at blood flow rates up to 450 mL/min. ESKD patients (40-75 years old) on thrice weekly outpatient HD were eligible. After a one-week HD run-in, patients received LIXELLE plus HD at a blood flow rate of 250 mL/min (one week), followed by LIXELLE plus HD at a blood flow rate up to 450 mL/min (one week). These blood flow rates were tested with three LIXELLE column sizes in sequence (treatment = six weeks). B2M removal was assessed for each combination. 
Results: Ten patients with a historic intradialytic hypotension (IDH) rate of 0.42 events/HD session/patient were enrolled. Nine patients completed all combinations without IDH events (treatment IDH rate 0.56 events/HD session/patient). No treatment-emergent serious adverse events or significant changes in red blood cell, platelet, or complement indices except haptoglobin were reported. B2M reduction ratios and removal of select proteins (&lt;40 kDa) increased with escalating column size and blood flow rate. 
Conclusion: LIXELLE plus HD across all column sizes was safe and well-tolerated at blood flow rates up to 450 mL/min. Extent of B2M removal corresponded to column size-blood flow rate combinations. This EFS provides a risk profile to guide further studies of LIXELLE in ESKD patients at US-standard blood flow rates.
DOI: 10.5281/zenodo.10499398
title: The Framework of Indian Summer monsoon Low-Pressure Systems Neural Operator (LPSNO)

description: This repository contains the model codes of Low-Pressure Systems Neural Operator (LPSNO) and anomaly of MSLP predictions. The individual files in the repository are described below:

1) slp_prediction_fconv_train_2.h5 --> The trained model of LPSNO

2) SLP_prediction_linear_Fconv_train.py --> LPSNO model code in python

3) slpa_prediction_linear_Fconv.npz --> Prediction of daily MSLP anomaly (in numpy array format)

4) Fconv_loss_1.npz --> The validation and training loss values of LPSNO model (in numpy array format)

5) mslp_ano_ERA5_1979_2018_ind.npz --> The MSLP anomaly using the ERA5 reanalysis data from 1979 -- 2018 used for training and validation (in numpy array format)
DOI: 10.5281/zenodo.10499399
title: The Framework of Indian Summer monsoon Low-Pressure Systems Neural Operator (LPSNO)

description: This repository contains the model codes of Low-Pressure Systems Neural Operator (LPSNO) and anomaly of MSLP predictions. The individual files in the repository are described below:

1) slp_prediction_fconv_train_2.h5 --> The trained model of LPSNO

2) SLP_prediction_linear_Fconv_train.py --> LPSNO model code in python

3) slpa_prediction_linear_Fconv.npz --> Prediction of daily MSLP anomaly (in numpy array format)

4) Fconv_loss_1.npz --> The validation and training loss values of LPSNO model (in numpy array format)

5) mslp_ano_ERA5_1979_2018_ind.npz --> The MSLP anomaly using the ERA5 reanalysis data from 1979 -- 2018 used for training and validation (in numpy array format)
DOI: 10.5281/zenodo.10489291
title: mgdc0013-annot-semseg-mgdc0001

description: Annotations for semantic segmentation to Multi-view image dataset of soybean individuals (Enrei, Zairai 51–2, Aoakimame, Saga zairai) (mgdc0001).
DOI: 10.5281/zenodo.10489292
title: mgdc0013-annot-semseg-mgdc0001

description: Annotations for semantic segmentation to Multi-view image dataset of soybean individuals (Enrei, Zairai 51–2, Aoakimame, Saga zairai) (mgdc0001).
DOI: 10.6084/m9.figshare.24183702.v2
title: Untitled Item

description: Raw dataset
DOI: 10.21227/v2xc-4626
title: Blood_Dataset(HH)

description: Since the majority of people have smartphones, the Hb level can be determined using the smartphone's video through PPG signal as opposed to the traditional approaches, which still require the use of a needle to puncture a vein. This study enrolled 108 subjects who underwent a clinical test, with their hemoglobin (Hb) level within the range of 6.6 to 16.5 g/dL. To mitigate potential variability in Hb levels during a brief period, 15-second recordings of the pointer finger were captured by utilizing a smartphone prior to the clinical test.  When the user places their finger on the phone's camera to record data, the camera flashlight briefly illuminates the area. The captured video is transformed to 60 fps as capturing a PPG signal at 60 fps provides a more detailed and accurate representation of changes in blood volume and heart rate compared to a lower frame rate.
DOI: 10.5281/zenodo.10416596
title: Sequential

description: Sequential Datasets.
DOI: 10.5281/zenodo.10499510
title: Sequential

description: Sequential Datasets.
DOI: 10.5281/zenodo.7684495
title: Sequential

description: Sequential Datasets.
DOI: 10.5281/zenodo.7684496
title: Sequential

description: Sequential Datasets.
DOI: 10.5281/zenodo.7866203
title: Sequential

description: Sequential Datasets.
DOI: 10.34740/kaggle/dsv/7393284
title: 📒 Meta Kaggle ported to MS SQL SERVER 2022 DB
DOI: 10.5517/ccdc.csd.cc2bcz1r
title: CCDC 2156454: Experimental Crystal Structure Determination

description: Related Article: Yu Zhang, Guisheng Deng|2023|J.Org.Chem.|89|80|doi:10.1021/acs.joc.3c01527
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.6084/m9.figshare.24993954
title: GPSC pangenome analysis

description: The data represents core genomes of major GPSC types and Indian Pneumococcal Pangenome (file name: coreGenome.*). All the raw data is presented in the supplementary file.
DOI: 10.6084/m9.figshare.24993954.v1
title: GPSC pangenome analysis

description: The data represents core genomes of major GPSC types and Indian Pneumococcal Pangenome (file name: coreGenome.*). All the raw data is presented in the supplementary file.
DOI: 10.6084/m9.figshare.23904282
title: Wildboar post-mortem interval estimation

description: Estimating the post-mortem interval of wild boar carcasses from season, decay stage, habitat, temperature and carrion beetles
DOI: 10.6084/m9.figshare.23867940.v2
title: Data of Development and Application of an assessment model coupled fish spawning and reproduction habitat

description: This data belongs to the basic data required for the calibration of model parameters, model validation and calculations in the paper entitled Development and Application of an assessment model coupled fish spawning and reproduction habitat, which also includes data on the results of the calculations in the paper
DOI: 10.25345/c5gt5fs16
title: MassIVE MSV000093859 - Proteomic analysis of gastric cancero patient-derived tissue ECM
title: Gastric cancer (GC) is a highly heterogeneous disease regarding histologic features, genotypes, and molecular phenotypes. Here, we investigated extracellular matrix (ECM)-centric analysis, examining its association with histologic subtypes and patient prognosis in human gastric cancer. We performed quantitative proteomic analysis of decellularized GC tissues that uncovered tumorous ECM, highlighting intertumoral heterogeneity in ECM composition. We identified 20 tumor-enriched proteins including four glycoproteins, serpin family H Member 1 (SERPINH1), Annexin family (ANXA3/4/5/13), S100A family (S100A6/8/9), MMP14, and other matrisome-associated proteins. In addition to these overall tumor-specific ECM proteins, histopathological characteristics of GC revealed variations in ECM composition, with the poorly cohesive carcinoma not otherwise specified (PCC-NOS) subtype being distinctly demarcated from other histologic subtypes. Integrating ECM proteomics with single-cell RNA sequencing, we identified crucial molecular markers in the PCC-NOS-specific stroma. PCC-NOS-enriched matrisome proteins (PEMs) and gene expression signatures of adipogenic cancer-associated fibroblasts (CAFadi) were closely linked, both associated with adverse outcomes in GC. Using tumor microarray analysis, we confirmed the CAFadi surface marker, ATP binding cassette subfamily A member 8 (ABCA8), predominantly present in PCC-NOS tumors. Our ECM-focused approach in identifying stromal characteristics paves the way for studies to determine their utility as biomarkers for patient stratification, offering valuable insights for linking molecular and histologic features in GC.
DOI: 10.5519/qd.ulo7yapg
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (110 records)
DOI: 10.18170/dvn/xigfuh
title: ICON FUV L2.5 veriefied data product

description: This is an update of ICON FUV L2.5 data product
DOI: 10.34740/kaggle/dsv/7393550
title: crypto-data-daily-updates
DOI: 10.34740/kaggle/dsv/7393581
title: crypto-data-daily-updates
DOI: 10.6084/m9.figshare.24993975
title: Supplementary Material for: Effects of extracorporeal blood flow rates on patient tolerance for LIXELLE® treatment during outpatient hemodialysis

description: Introduction: Accumulation of β2-microglobulin (B2M) in dialysis patients contributes to several comorbidities of end stage kidney disease (ESKD). The LIXELLE® device adsorbs B2M from blood using sorbent bead technology. Studies in Japan showed LIXELLE treatment during hemodialysis (HD) at blood flow rates up to 250 mL/min removes B2M above HD alone and is well-tolerated. We investigated tolerance for LIXELLE treatment during HD at higher HD blood flow rates standard in the United States (US).
Methods: A prospective, open-label, non-randomized, single arm, early feasibility study (EFS) assessed tolerance and safety of LIXELLE treatment during HD at blood flow rates up to 450 mL/min. ESKD patients (40-75 years old) on thrice weekly outpatient HD were eligible. After a one-week HD run-in, patients received LIXELLE plus HD at a blood flow rate of 250 mL/min (one week), followed by LIXELLE plus HD at a blood flow rate up to 450 mL/min (one week). These blood flow rates were tested with three LIXELLE column sizes in sequence (treatment = six weeks). B2M removal was assessed for each combination. 
Results: Ten patients with a historic intradialytic hypotension (IDH) rate of 0.42 events/HD session/patient were enrolled. Nine patients completed all combinations without IDH events (treatment IDH rate 0.56 events/HD session/patient). No treatment-emergent serious adverse events or significant changes in red blood cell, platelet, or complement indices except haptoglobin were reported. B2M reduction ratios and removal of select proteins (&lt;40 kDa) increased with escalating column size and blood flow rate. 
Conclusion: LIXELLE plus HD across all column sizes was safe and well-tolerated at blood flow rates up to 450 mL/min. Extent of B2M removal corresponded to column size-blood flow rate combinations. This EFS provides a risk profile to guide further studies of LIXELLE in ESKD patients at US-standard blood flow rates.
DOI: 10.6084/m9.figshare.24993975.v1
title: Supplementary Material for: Effects of extracorporeal blood flow rates on patient tolerance for LIXELLE® treatment during outpatient hemodialysis

description: Introduction: Accumulation of β2-microglobulin (B2M) in dialysis patients contributes to several comorbidities of end stage kidney disease (ESKD). The LIXELLE® device adsorbs B2M from blood using sorbent bead technology. Studies in Japan showed LIXELLE treatment during hemodialysis (HD) at blood flow rates up to 250 mL/min removes B2M above HD alone and is well-tolerated. We investigated tolerance for LIXELLE treatment during HD at higher HD blood flow rates standard in the United States (US).
Methods: A prospective, open-label, non-randomized, single arm, early feasibility study (EFS) assessed tolerance and safety of LIXELLE treatment during HD at blood flow rates up to 450 mL/min. ESKD patients (40-75 years old) on thrice weekly outpatient HD were eligible. After a one-week HD run-in, patients received LIXELLE plus HD at a blood flow rate of 250 mL/min (one week), followed by LIXELLE plus HD at a blood flow rate up to 450 mL/min (one week). These blood flow rates were tested with three LIXELLE column sizes in sequence (treatment = six weeks). B2M removal was assessed for each combination. 
Results: Ten patients with a historic intradialytic hypotension (IDH) rate of 0.42 events/HD session/patient were enrolled. Nine patients completed all combinations without IDH events (treatment IDH rate 0.56 events/HD session/patient). No treatment-emergent serious adverse events or significant changes in red blood cell, platelet, or complement indices except haptoglobin were reported. B2M reduction ratios and removal of select proteins (&lt;40 kDa) increased with escalating column size and blood flow rate. 
Conclusion: LIXELLE plus HD across all column sizes was safe and well-tolerated at blood flow rates up to 450 mL/min. Extent of B2M removal corresponded to column size-blood flow rate combinations. This EFS provides a risk profile to guide further studies of LIXELLE in ESKD patients at US-standard blood flow rates.
DOI: 10.6084/m9.figshare.23867940
title: <b>An Assessment Model Coupled Fish Spawning and Reproduction Habitat to Investigate Resilience Patterns for Fish Biodiversity Reduction</b>

description: This data belongs to the basic data required for the calibration of model parameters, model validation and calculations in the paper entitled An Assessment Model Coupled Fish Spawning and Reproduction Habitat to Investigate Resilience Patterns for Fish Biodiversity Reduction, which also includes data on the results of the calculations in the paper
DOI: 10.6084/m9.figshare.23867940.v4
title: <b>An Assessment Model Coupled Fish Spawning and Reproduction Habitat to Investigate Resilience Patterns for Fish Biodiversity Reduction</b>

description: This data belongs to the basic data required for the calibration of model parameters, model validation and calculations in the paper entitled An Assessment Model Coupled Fish Spawning and Reproduction Habitat to Investigate Resilience Patterns for Fish Biodiversity Reduction, which also includes data on the results of the calculations in the paper
DOI: 10.6084/m9.figshare.23867940.v3
title: <b>An Assessment Model Coupled Fish Spawning and Reproduction Habitat to Investigate Resilience Patterns for Fish Biodiversity Reduction</b>

description: This data belongs to the basic data required for the calibration of model parameters, model validation and calculations in the paper entitled An Assessment Model Coupled Fish Spawning and Reproduction Habitat to Investigate Resilience Patterns for Fish Biodiversity Reduction, which also includes data on the results of the calculations in the paper
DOI: 10.34740/kaggle/dsv/7393604
title: crypto-data-daily-updates
DOI: 10.14469/hpc/13605
title: Video Files in MPEG-4 Format

description: Historic Video collection
DOI: 10.34740/kaggle/ds/4298351
title: Sunlife 🇵🇭 Mutual Funds 20+ years Daily Data 📈
DOI: 10.6084/m9.figshare.24993978
title: supplementary dataset

description: The data set is related to a study on comparing topics, impact, disciplines, and research methods in articles published from 2016 to 2020 between <i>Scientometrics</i> and <i>Journal of Informetrics</i> (<i>JOI</i>)
DOI: 10.5281/zenodo.10488614
title: Single-stage Synchronous India-Asia collision model indicated by Himalayan high-pressure metamorphic rocks
DOI: 10.5281/zenodo.10488615
title: Single-stage Synchronous India-Asia collision model indicated by Himalayan high-pressure metamorphic rocks
DOI: 10.6084/m9.figshare.24993996.v1
title: Supporting information dataset.xlsx

description: Sheet S1 Basic description of Sampling sites; Sheet S2 Normalized abundance of ARGs with different mechanisms (copies per cell number); Sheet S3 Normalized abundance of ARGs (copies per 16S rRNA copies); Sheet S4 Abundance of ARG subtypes (per cell number); Sheet S5 Abundance of ARG subtypes (per 16S rRNA copies); Sheet S6 Classification of resistance mechanism of TRGs.
DOI: 10.5281/zenodo.10499726
title: Medios R.Aysen y métricas a septiembre 2022
DOI: 10.5281/zenodo.10499727
title: Medios R.Aysen y métricas a septiembre 2022
DOI: 10.5281/zenodo.10499717
title: Focused mantle upwelling beneath the Southeastern Asian Basalt Province revealed by seismic surface wave tomography

description: This dataset contains the earthquake waveforms, the manually picked surface wave dispersion data, and the final inverted 3-D Vs model data for our research paper "Focused mantle upwelling beneath the Southeastern Asian Basalt Province revealed by seismic surface wave tomography", which has been published in Geophysical Research Letters (https://doi.org/10.1029/2023GL104336).
DOI: 10.5281/zenodo.7501564
title: outdated

description: This dataset is outdated. Please check the updated one.
DOI: 10.5281/zenodo.7867772
title: Focused mantle upwelling beneath the Southeastern Asian Basalt Province revealed by seismic surface wave tomography

description: This dataset contains the earthquake waveforms, the manually picked surface wave dispersion data, and the final inverted 3-D Vs model data for our research paper "Focused mantle upwelling beneath the Southeastern Asian Basalt Province revealed by seismic surface wave tomography".
DOI: 10.34740/kaggle/dsv/7393874
title: Egypt Gold Prices | Daily Updated
DOI: 10.34740/kaggle/dsv/7393884
title: crypto-data-daily-updates
DOI: 10.6084/m9.figshare.24993999
title: Business management in the economy of artificial intelligence / Менеджмент бизнеса в экономике искусственного интеллекта

description: The dataset contains international statistics for 56 countries of the world (both developed and developing) at the beginning of 2023, reflecting the results of 2022. If there is a shortage of data, earlier values of indicators were taken. The statistics are systematized in terms of the elements of the author's PLUD-analysis method: productivity, limits, sustainability and friendliness. The dataset allows for automated analytics of business management in the artificial intelligence economy.Productivity: GDP per hour worked (GDP constant 2017 international $ at PPP) in 2021; Medium and high-tech manufacturing value added (% manufacturing value added); High-technology exports (current US$); High-technology exports (% of manufactured exports).Limitations: Business efficiency, score 0-100; Use of big data and analytics, score 0-10; E-Participation, score 0-1; Equal opportunity, score 0-10.Sustainability: Market capitalization of listed domestic companies (% of GDP); Renewable energy consumption (% of total final energy consumption); CO2 emissions (metric tons per capita); Global cybersecurity index, score 0-100.Friendliness: Tertiary enrolment, % gross; Research and development (R&D); Knowledge-intensive employment, %; GERD performed by business, % GDP.На русском языке (In Russian):Датасет содержит международную статистику по 56 странам мира (как развитым, так и развивающимся) на начало 2023 г., отражающую итоги 2022 г. При дефиците данных взяты более ранние значения показателей. Статистика систематизирована в разрезе элементов авторского метода ПЛУД-анализа: производительность, лимиты, устойчивость и дружественность. Датасет позволяет проводить автоматизированную аналитику менеджмента бизнеса в экономике искусственного интеллекта.Производительность: Производительность труда на 1 работника в час, долл.; Средне- и высокотехнологичные производства, % валовой добавленной стоимости в промышленности; Высокотехнологичный экспорт, долл. в текущих ценах; Высокотехнологичный экспорт, % промышленного экспорта.Лимиты: Эффективность бизнеса, баллы 1-100; Аналитика больших данных, баллы 1-10; Электронные коммуникации, баллы 0-1; Равенство возможностей, баллы 0-10.Устойчивость: Рыночная капитализация компаний, % ВВП; Доля потребления возобновляемой энергии, %; Выбросы углерода, метрич. Т. На душу населения; Кибербезопасность, баллы 0-100.Дружественность: Подготовка кадров высшей квалификации, %; НИОКР, баллы 1-100; Знаниеемкая занятость, %; Финансирование НИОКР бизнесом, % ВВП.